These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2901687)

  • 1. Occurrence of pyroglutamyl peptidase II, a specific TRH degrading enzyme in rabbit retinal membranes and in human retinoblastoma cells.
    Wilk S; Suen CS; Wilk EK
    Neuropeptides; 1988 Jul; 12(1):43-7. PubMed ID: 2901687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroglutamyl peptidase II inhibition specifically increases recovery of TRH released from rat brain slices.
    Charli JL; Mendez M; Vargas MA; Cisneros M; Assai M; Joseph-Bravo P; Wilk S
    Neuropeptides; 1989 Oct; 14(3):191-6. PubMed ID: 2575716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of thyrotropin releasing hormone degrading enzymes in rat brain and pituitary by L-3,5,3'-triiodothyronine.
    Suen CS; Wilk S
    J Neurochem; 1989 Mar; 52(3):884-8. PubMed ID: 2563758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid inactivation and phosphorylation of pyroglutamyl peptidase II in Y-79 human retinoblastoma cells after exposure to phorbol ester.
    Suen CS; Wilk S
    Endocrinology; 1990 Dec; 127(6):3038-46. PubMed ID: 1979029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution of the membrane-bound pyroglutamate amino peptidase-degrading thyrotropin-releasing hormone in rat brain.
    Vargas M; Mendez M; Cisneros M; Joseph-Bravo P; Charli JL
    Neurosci Lett; 1987 Aug; 79(3):311-4. PubMed ID: 2889173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of substrate requirements, kinetic properties, and competive inhibitors of the enzymes catabolizing TRH in rat brain.
    Busby WH; Youngblood WW; Kizer JS
    Brain Res; 1982 Jun; 242(2):261-70. PubMed ID: 6126250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase.
    Friedman TC; Wilk S
    J Neurochem; 1986 Apr; 46(4):1231-9. PubMed ID: 2869108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-releasing hormone-degrading enzyme in human serum is classified as type II of pyroglutamyl aminopeptidase: influence of thyroid status.
    Yamada M; Mori M
    Proc Soc Exp Biol Med; 1990 Sep; 194(4):346-51. PubMed ID: 1975097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium butyrate induces pyroglutamyl peptidase I and decreases thyrotropin-releasing hormone receptors in GH3 cells.
    Suen CS; Wilk S
    Endocrinology; 1989 Apr; 124(4):1654-60. PubMed ID: 2564336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation and regulation of pyroglutamyl peptidase II messenger RNA levels in rat tissues and GH3 cells.
    Lin J; Wilk S
    Neuroendocrinology; 1998 Mar; 67(3):197-208. PubMed ID: 9630437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide-specific peptidases: does brain contain a specific TRH-degrading enzyme?
    Wilk S
    Life Sci; 1986 Oct; 39(17):1487-92. PubMed ID: 3093794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of pyroglutamyl peptidase II synthesis by phorbol ester in the Y-79 retinoblastoma cell.
    Suen CS; Wilk S
    Endocrinology; 1991 Apr; 128(4):2169-74. PubMed ID: 1672274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of pyroglutamyl peptidase II in rabbit brain, spinal cord, and organs.
    Vargas MA; Cisneros M; Herrera J; Joseph-Bravo P; Charli JL
    Peptides; 1992; 13(2):255-60. PubMed ID: 1357633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyroglutamyl peptidase: an overview of the three known enzymatic forms.
    Cummins PM; O'Connor B
    Biochim Biophys Acta; 1998 Dec; 1429(1):1-17. PubMed ID: 9920379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of a thyrotropin-releasing hormone-degrading enzyme in GH3 cells: induction of pyroglutamyl peptidase I by 3,5,3'-triiodothyronine.
    Suen CS; Wilk S
    Endocrinology; 1987 Aug; 121(2):770-5. PubMed ID: 2885183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of prolyl endopeptidase, pyroglutamyl peptidase I, TRH, and its metabolites in rat pancreas.
    Salers P; Ouafik LH; Giraud P; Maltese JY; Dutour A; Oliver C
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E845-50. PubMed ID: 1352085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of a membrane bound pyroglutamyl amino peptidase degrading thyrotropin releasing hormone in rat brain.
    Garat B; Miranda J; Charli JL; Joseph-Bravo P
    Neuropeptides; 1985 Mar; 6(1):27-40. PubMed ID: 2859545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibitors of pyroglutamyl peptidase I and prolyl endopeptidase do not change the in vitro release of TRH or its content in rodent brain.
    Charli JL; Mendez M; Joseph-Bravo P; Wilk S
    Neuropeptides; 1987; 9(4):373-8. PubMed ID: 2886950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for pyroglutamyl peptidase I and prolyl endopeptidase activities in the rat insulinoma cell line RINm 5F: lack of relationship with TRH metabolism.
    Salers P; Ouafik LH; Giraud P; Dutour A; Maltese JY; Oliver C
    Mol Cell Biochem; 1991 Jul; 106(1):15-24. PubMed ID: 1681421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some events of thyrotropin-releasing hormone metabolism are regulated in lactating and cycling rats.
    Uribe RM; Joseph-Bravo P; Pasten J; Ponce G; Méndez M; Covarrubias L; Charli JL
    Neuroendocrinology; 1991 Nov; 54(5):493-8. PubMed ID: 1684228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.